AlaskOmega Line Grows with New Omega-7 Concentrate
Organic Technologies says its new omega-7 concentrate allows for higher label claims and more competitive prices than omega-7s from sea buckthorn oil.
Photo © iStockphoto.com/numbeos
Organic Technologies (Coshocton, OH) has announced it is adding a new omega-7 ingredient to its existing AlaskOmega line of marine ingredients. The new, MSC-certified AlaskOmega Omega-7 Palmitoleic 500 concentrate is derived from wild Alaska Pollock and contains a minimum of 50% omega-7, according to Organic Technologies.
Omega-7s have shown potential health benefits in the areas of heart health, insulin sensitivity, anti-inflammation, moisture replenishment of mucosal membranes, antimicrobial effects, and anti-aging effects for skin, hair, and nail, explains Organic Technologies.
The company says that because its new omega-7 concentrate allows for a more potent concentration of omega-7 than other sources, it will allow formulators “to achieve higher omega-7 label claims and use smaller capsules sizes versus other traditional omega-7 sources, such as sea buckthorn oil, at a more competitive price.”
“We see the omega-7 category growing as customers search for new, clinically documented products and formulation ideas within the ‘omega’ space,” says Dan Wiley, vice president of nutrition and health at Organic Technologies. “Organic Technologies is positioning our AlaskOmega Omega-7 Palmitoleic 500 concentrate as a high-strength omega-7 alternative-basically a double-strength sea buckthorn oil, at a more competitive price.”
Read more:
AlaskOmega Brand Imposes Even Stricter Fish-Oil Freshness Standards
Fishy Finds: New Marine Ingredients in the Omega Market
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
